UICC-ARO Symposium at the UICC 2016 World Cancer Congress How Can We Mobilize Action to Realize UHC in Asia?
UICC-ARO Symposium at the UICC 2016 World Cancer Congress How Can We Mobilize Action to Realize UHC in Asia?
复制标题
UICC-ARO研讨会在UICC 2016世界癌症大会上，我们如何动员行动以实现亚洲的UHC？
DOI：
10.22034/apjcp.2017.18.11.2897
复制
发表时间：
2017-11-26
期刊：
影响因子：
--
通讯作者：
Nozaki S
中科院分区：
文献类型：
--
作者：
Akaza H;Kawahara N;Fukuda T;Horie S;Thabrany H;Nozaki S
2016年11月，由国际癌症研究所组织的2016年世界癌症大会在巴黎举行，主题为“动员行动-促进变革”。作为主题为“加强癌症控制：优化卫生系统成果”的第4轨道发言的一部分，国际药物管制大学亚洲区域办事处（UICC-ARO）举行了一次专题讨论会，讨论动员行动在亚洲实现全民健康覆盖的问题。在介绍研讨会时，Hideyuki Akaza指出，全民健康覆盖（UHC）已被纳入可持续发展目标，实现UHC的关键问题之一将是如何平衡患者需求与癌症经济负担。来自日本和印度尼西亚的发言者讨论了各种问题，包括亚洲医疗经济评估的现状和挑战、资源分层的重要性、精准医疗的前景以及亚洲发展中国家和新兴国家癌症控制和UHC的前景。提出的关键问题包括如何应对随着新的和越来越昂贵的药物进入市场而导致的癌症治疗费用上升。发言者和与会者指出，亚洲各地正在制定卫生技术评估方案，以便在国家卫生系统面临日益严峻的预算限制的情况下，评估药物的成本效益。还指出了筛查和早期发现的重要性，认为这是有可能减少对晚期癌症昂贵药物依赖的有效手段。研讨会由Hideyuki Akaza和Shinjiro Nozaki（世卫组织科比中心）共同主持。
The 2016 World Cancer Congress, organised by UICC, was held in Paris in November 2016, under the theme “Mobilizing action – Inspiring Change.” As part of Track 4 presentations on the theme of “Strengthening cancer control: optimizing outcomes of health systems,” UICC-Asian Regional Office (UICC-ARO) held a symposium to discuss the issue of mobilizing action to realize UHC in Asia. Introducing the symposium, Hideyuki Akaza noted that universal health coverage (UHC) is included in the Sustainable Development Goals and one of the key issues for achieving UHC will be how to balance patient needs with the economic burden of cancer. Speakers from Japan and Indonesia addressed various issues, including the current status and challenges for medical economic evaluation in Asia, the importance of resource stratification, prospects for precision medicine, and the outlook for cancer control and UHC in developing and emerging countries in Asia. Key issues raised included how to respond to the rising costs of treating cancer as new and increasingly expensive drugs come to the market. Speakers and participants noted that health technology assessment programs are being developed around Asia in order to evaluate the cost-effectiveness of drugs in the face of budgetary constraints within increasingly pressurized national health systems. The importance of screening and early detection was also noted as effective means that have the potential to reduce reliance on expensive drugs for advanced cancers. The symposium was chaired jointly by Hideyuki Akaza and Shinjiro Nozaki (WHO Kobe Centre).